Immediate Impact

2 from Science/Nature 51 standout
Sub-graph 1 of 24

Citing Papers

Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Meta-hallmarks of aging and cancer
2023 Standout
2 intermediate papers

Works of Phillip Barnette being referenced

Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
2012
Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
2009

Author Peers

Author Last Decade Papers Cites
Phillip Barnette 245 174 248 185 26 651
Hassan El‐Solh 92 167 222 260 38 677
Cécile Verite 216 219 105 138 38 677
Nalini Jayaprakash 142 139 191 219 21 797
Amy Early 265 344 224 150 29 628
J.C. Gentet 144 61 152 118 20 598
Donald K. Strickland 114 130 154 103 36 646
Jane Renshaw 100 99 119 526 19 661
Alain Sadoun 123 425 242 128 28 803
Robert Golbey 110 69 166 178 27 653
Susana Vives 225 505 202 260 35 749

All Works

Loading papers...

Rankless by CCL
2026